SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-053263
Filing Date
2024-04-29
Accepted
2024-04-29 06:03:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm244019d2_defa14a.htm DEFA14A 14963
2 GRAPHIC tm244019d2_defa14aimg001.jpg GRAPHIC 166436
3 GRAPHIC tm244019d2_defa14aimg002.jpg GRAPHIC 172083
  Complete submission text file 0001104659-24-053263.txt   482425
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38410 | Film No.: 24886364
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)